May 2005
 |
| Features |
 |


 |
Anti-inflammatory Drugs Offer Promise |
| |
by John D. Zoidis, MD |
| |
Insight into the pathogenesis of asthma has been key in the development of drug treatments. |
 |
 |
 |
Reducing the Risk of Asthma Exacerbations |
| |
by Carlos A. Camargo Jr, MD, DrPH, and Pankaj Patel, PharmD |
| |
Despite their proven effectiveness, ICS are underused in the treatment of asthmatic children. As well, inappropriate devices and techniques result in suboptimal dosing. |
 |
 |
 |
Environmental Triggers |
| |
by Rick Carter, PhD, MBA; Stuart H. Tedders, PhD; Brian Tiep, MD; Anthony V. Parrillo, PhD, CHES; and Barry Joyner, PhD |
| |
Although the causes of asthma are unknown, researchers do know that environmental and genetic factors contribute to its onset. |
 |
 |
 |
Pulmonary Function Testing |
| |
by Theodore G. Liou, MD, and Richard E. Kanner, MD |
| |
Adherence to standard methods is crucial to ensuring that PFTs from different facilities and different devices produce the same results. Part 1 of 2. |
 |
 |
 |
High Frequency Ventilation |
| |
by Michael R. Jackson, RRT-NPS, CPFT |
| |
RTs must be alert to obstructions and malpositioned endotracheal tubes during HFV. |
 |
|
 |
 |
 |
 |
 |

 |
| Departments |
 |

|
|
|
 |
|